Atherosclerosis. Description and mechanisms. Part 2: mechanisms
Capron, L.
Revue Neurologique (Paris) 139(4): 239-250
1983
ISSN/ISBN: 0035-3787 PMID: 6612139 Document Number: 209924
Document emailed within 1 workday
Related Documents
Ponisovskiy, M.R. 2011: Driving mechanisms of passive and active transport across cellular membranes as the mechanisms of cell metabolism and development as well as the mechanisms of cellular distance reactions on hormonal expression and the immune response Critical Reviews in Eukaryotic Gene Expression 21(3): 267-290Schaffner, T.; Zimmermann, A.; Keller, H.U.; Locher, G.W.; Cottier, H. 1978: Influence of immunologic mechanisms on atherosclerosis Die Medizinische Welt 29(27-28): 1118-1122
Dzau, V.J. 1990: Atherosclerosis and hypertension: mechanisms and interrelationships Journal of Cardiovascular Pharmacology 15(Suppl 5): S59-S64
Haller, H. 1993: Calcium antagonists and cellular mechanisms of glomerulosclerosis and atherosclerosis American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 21(6 Suppl 3: 26-31
Shershnev, V.G.; Simochkina, Z.A.; Dotsenko, I.N. 1971: State of respiratory regulatory mechanisms in coronary atherosclerosis Terapevticheskii Arkhiv 43(2): 49-53
Capron, L. 1995: Description and mechanisms of sclerotic arterial diseases of the lower limbs La Revue du Praticien 45(1): 25-30
Lau, J.Y. 1998: Mechanisms of hepatic toxicity. IV. Pathogenetic mechanisms involved in hepatitis C virus-inducedliver diseases American Journal of Physiology 275(6): G1217-G1220
Orosz, C.G.; Bishop, D.K.; Ferguson, R.M. 1989: In vivo mechanisms of alloreactivity. VI. Evidence that alloantigen deposition initiates both local and systemic mechanisms that influence CTL accumulation at a graft site Transplantation 48(5): 818-824
Kirkland, E.B.; Hantash, B.M. 2012: Microdermabrasion: molecular mechanisms unraveled, part 1 Journal of Drugs in Dermatology: Jdd 11(9): E2-E9
Kirkland, E.B.; Hantash, B.M. 2012: Microdermabrasion: molecular mechanisms unraveled, part 2 Journal of Drugs in Dermatology: Jdd 11(9): E10-E17
Băncescu, G.; Băncescu, A. 2003: Oral streptococci: factors and mechanisms of pathogenicity (part II) Bacteriologia Virusologia Parazitologia Epidemiologia 48(2-3): 93-98
Ffrench, R.; Stewart, G.J.; Penny, R.; Levy, J.A. 1996: Managing HIV. Part 3. Mechanisms of disease. 3.2 how HIV produces immune deficiency Medical Journal of Australia 164(3): 166-171
Carr, A.; Garsia, R. 1996: Managing HIV. Part 3: Mechanisms of disease. 3.5 how HIV leads to hypersensitivity reactions Medical Journal of Australia 164(4): 227-229
Borges Dinis, P.; Gomes, A. 1991: Immunologic mechanisms in secretory otitis media-recent concepts (Part II) Allergie et Immunologie 23(3): 81-87
Nachkebia, J.; Kvachadze, I.; Tsibadze, A. 2005: Differential description of heart rate regulatory mechanisms of young men at sensory-motor and psychoemotional load during high frequency sound exposure Georgian Medical News 122: 57-60
Ulvund, M.J. 1972: Tumour and immunity. I. General part. Theories on carcinogenesis. Immune defense mechanisms Nordisk Veterinaermedicin 24(7): 370-379
Youle, R J. 2003: Haya Lorberboum-Galski and Philip Lazarovici (Eds.). Chimeric Toxins: Mechanisms of Action and Therapeutic Applications (Cell and Molecular Mechanisms of Toxin Action) International Journal of Toxicology 22(4): 331-332
Vadász, D.áv.; Sztriha, L.ás.ó K.; Sas, K.; Vécsei, L.ás.ó 2013: Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part II: Potential causes and laboratory tests Ideggyogyaszati Szemle 66(1-2): 15-22
Gilbert, E.; Hui, A.; Waldorf, H.A. 2012: The basic science of dermal fillers: past and present Part I: background and mechanisms of action Journal of Drugs in Dermatology: Jdd 11(9): 1059-1068
Velichnovskiĭ, B.T. 1998: The main pathogenetic mechanisms in occupational diseases of lungs of dust-related etiology. Part I. from an experiment to a concept Meditsina Truda i Promyshlennaia Ekologiia 10: 28-38